George J. Scott

Family Medicine

854 S White Horse Pike Unit 4
Hammonton, NJ 08037

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 6 publications

The IL-33 and IL-4Rα blocking antibodies itepekimab and dupilumab modulate both distinct and common inflammatory mediators in asthma.

The IL-33 and IL-4Rα blocking antibodies itepekimab and dupilumab modulate both distinct and common inflammatory mediators in asthma.

Journal: Science translational medicine

Published: October 29, 2025

Blocking common γ chain cytokine signaling ameliorates T cell-mediated pathogenesis in disease models.

Blocking common γ chain cytokine signaling ameliorates T cell-mediated pathogenesis in disease models.

Journal: Science translational medicine

Published: January 11, 2023

IL-4 and IL-13, not eosinophils, drive type 2 airway inflammation, remodeling and lung function decline.

IL-4 and IL-13, not eosinophils, drive type 2 airway inflammation, remodeling and lung function decline.

Journal: Cytokine

Published: August 14, 2022

Dual blockade of IL-4 and IL-13 with dupilumab, an IL-4Rα antibody, is required to broadly inhibit type 2 inflammation.

Dual blockade of IL-4 and IL-13 with dupilumab, an IL-4Rα antibody, is required to broadly inhibit type 2 inflammation.

Journal: Allergy

Published: August 26, 2019

IL-33 blockade affects mediators of persistence and exacerbation in a model of chronic airway inflammation.

IL-33 blockade affects mediators of persistence and exacerbation in a model of chronic airway inflammation.

Journal: The Journal of allergy and clinical immunology

Published: June 09, 2019

The importance of chromatographic resolution when analyzing steroid biomarkers.

The importance of chromatographic resolution when analyzing steroid biomarkers.

Journal: Steroids

Published: June 06, 2014

Showing 1-6 of 6

Last Updated: 09/26/2026